Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer

Hibah M. Aldawsari, Sima Singh, Nabil A. Alhakamy, Rana B. Bakhaidar, Abdulrahman A. Halwani, Nagaraja Sreeharsha, Shaimaa M. Badr-Eldin

Open source

DOI
10.3390/ph15050544
Published
2022-04-28
Container
Pharmaceuticals
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph15050544,
  title = {Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer},
  author = {Hibah M. Aldawsari and Sima Singh and Nabil A. Alhakamy and Rana B. Bakhaidar and Abdulrahman A. Halwani and Nagaraja Sreeharsha and Shaimaa M. Badr-Eldin},
  year = {2022},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph15050544},
  url = {https://doi.org/10.3390/ph15050544}
}

RIS

TY  - JOUR
TI  - Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer
AU  - Hibah M. Aldawsari
AU  - Sima Singh
AU  - Nabil A. Alhakamy
AU  - Rana B. Bakhaidar
AU  - Abdulrahman A. Halwani
AU  - Nagaraja Sreeharsha
AU  - Shaimaa M. Badr-Eldin
PY  - 2022
JO  - Pharmaceuticals
DO  - 10.3390/ph15050544
UR  - https://doi.org/10.3390/ph15050544
ER  - 

APA

Aldawsari, H. M., Singh, S., Alhakamy, N. A., Bakhaidar, R. B., Halwani, A. A., Sreeharsha, N., & Badr-Eldin, S. M. (2022). Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer. Pharmaceuticals. https://doi.org/10.3390/ph15050544

Source records